Observational study on Erdheim-Chester disease
Part of Blood & lymphatic clinical trials.
This study collects information from patients with Erdheim-Chester disease (ECD) to better understand the condition and how it is treated. By looking at medical records, researchers hope to improve care for people with ECD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Erdheim-Chester disease (ECD) using the latest guidelines
- You or your parent/guardian can sign a consent form agreeing to join the study
- Your medical records have information about your diagnosis, genetic tests, treatments, and how you responded to them
- You have been seen by your doctor for at least one year after diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information about people diagnosed with rare histiocytic disorders. It helps doctors better understand these conditions over time and may improve future care.
This is a registry (a research database) for people with Erdheim-Chester disease and other related “histiocytosis” conditions. It collects past and future medical information to better understand these illnesses and support future research.
This study looks at what support caregivers of people with Erdheim-Chester disease and related rare conditions need. It may help improve caregiver support so families cope better while the patient is being treated.
This study is tracking people with a rare blood vessel tumor called epithelioid hemangioendothelioma (EHE) to learn more about how it behaves and how best to care for you. By joining, you'll help doctors improve future treatments for this condition.
This study looks at children ages 0–18 with eosinophilic gut disorders (EGIDs) to better understand these conditions and how they are managed. It may help doctors improve care by comparing real-world information from patients followed at participating hospitals.
This study collects information and biological samples to better understand what causes certain allergic/eosinophilic conditions. It may help researchers learn mechanisms and improve future care.
Hear when a new Erdheim-Chester Disease (ECD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.